Scarica l'app Stockscreener
14.32
3.18%
-0.47
Dopo l'orario di chiusura:
14.34
0.02
+0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MLTX Giù?
Forum
Previsione
Moonlake Immunotherapeutics Borsa (MLTX) Ultime notizie
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Investors to Today's Lead Plaintiff Deadline in Securities Class Action - PR Newswire
MoonLake Immunotherapeutics Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – MLTX - marketscreener.com
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of - GlobeNewswire
MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
Portnoy Law Firm Announces Class Action on Behalf of Moonlake Immunotherapeutics, Inc. Investors - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - Eagle-Tribune
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - Benzinga
MoonLake Immunotherapeutics (MLTX) Valuation After Sonelokimab Phase 3 Setback and Emerging Lawsuits - simplywall.st
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages - GlobeNewswire
MLTX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile
2025-12-14 | Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025 | NDAQ:MLTX | Press Release - Stockhouse
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Up 6%Still a Buy? - MarketBeat
Phase 3 Miss and Fraud Suits Could Be A Game Changer For MoonLake Immunotherapeutics (MLTX) - simplywall.st
MOONLAKE CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire
Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The AI Journal
MoonLake Immunotherapeutics Sued for Securities Law - GlobeNewswire
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit - marketscreener.com
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That MoonLake Immunotherapeutics Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action LawsuitHagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms - PR Newswire
MLTX DEADLINE: Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025MLTX - marketscreener.com
Have MoonLake Immunotherapeutics Insiders Been Selling Stock? - simplywall.st
MLTX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics ... - Caledonian Record
MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Sells $1,960,400.00 in Stock - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 70,000 Shares - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Kristian Reich Sells 72,908 Shares - MarketBeat
Investors who lost money on MoonLake Immunotherapeutics - GlobeNewswire
MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – - The National Law Review
MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake - GlobeNewswire
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025MLTX - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Top Executives Cash In on MoonLake Immunotherapeutics Stock! - TipRanks
MoonLake Immunotherapeutics(MLTX.US) Officer Sells US$3.01 Million in Common Stock - 富途牛牛
MOONLAKE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Understanding the Setup: (MLTX) and Scalable Risk - news.stocktradersdaily.com
Deadline Alert: MoonLake Immunotherapeutics (MLTX) - GlobeNewswire
Ready to Jump After Recent Trade: MoonLake Immunotherapeutics (MLTX) - setenews.com
MLTX NOTIFICATION: BFA Law Notifies MoonLake Immunotherapeutics Investors of the Pending Class Action Lawsuit and Upcoming December 15 Legal Deadline - TMX Newsfile
MLTX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class ActionMLTX - marketscreener.com
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Fa - GuruFocus
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman - PR Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of MoonLake Immunotherapeutics, Inc. Investors - GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SueWallSt Podcast Series Launches With Focus on MoonLake Immunotherapeutics (MLTX) Fraud Allegations - ACCESS Newswire
Marshall Wace LLP Sells 111,706 Shares of MoonLake Immunotherapeutics $MLTX - MarketBeat
Shareholders SueWallSt in New Class Action Against MoonLake ImmunotherapeuticsAct Now - ACCESS Newswire
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash - AOL.com
MLTX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class ActionMLTX - marketscreener.com
MLTX 1-WEEK DEADLINE ALERT: MoonLake Immunotherapeutics - GlobeNewswire
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - marketscreener.com
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER - GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeut - GuruFocus
Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) - Sahm
2025-12-07 | Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025 | NDAQ:MLTX | Press Release - Stockhouse
MLTX INVESTOR LOSSES: Lose Money on MoonLake - GlobeNewswire
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):